StageZero Life Sciences
  • About
    • Our Science
    • Publications
    • Board of Directors
    • Partners
    • Scientific Advisory Board
  • Cancer Testing
    • Aristotle-Test
    • AVRT Cancer Prevention
    • Employers
    • Firefighters
    • ColonSentry
  • Physicians
    • Establish an Account
    • Order Supplies
  • INVESTORS
    • Corporate Governance
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In the News
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment

We're On a Mission to Help Reduce the Incidence of Late Stage Cancer Through Early Interventions 

Today most cancer research is focused on the "Moonshot" a cure for cancer. But at StageZero Life Sciences we believe in "groundshots" too, by doing whatever we can to help improve outcomes through cancer prevention, earlier cancer detection and adjunctive cancer therapies. 
​​
​(TSX:SZLS) (OTCQB:SZLSF)
Watch us on Youtube
Picture
Learn More About our ARISTOTLE test by watching the video below.
Follow Us on Social Media!

StageZero listed warrants

​Please note that the recent TSX bulletin regarding the Trading Halt of the StageZero Listed warrants TSX Symbol: SZLS.WS, relates solely to the warrants.  These warrants have come to term and will no longer be trading.

Early Cancer Detection

StageZero Life Sciences is dedicated to finding cancer in the earliest stages when it is most curable. Our next-generation test, ARISTOTLE®, can simultaneously screen for multiple cancers from a single blood sample.  ARISTOTLE has been built on the company's mRNA Sentinel Principle Technology® Platform, which has been validated in more than 9,000 patients and used by more than 100,000 patients in North America. 
Cancer Prevention & Adjunctive Cancer Therapies
​
In addition to early cancer detection, our Care Oncology clinicians apply their expertise in metabolic oncology to oversee two critical programs that support our mission:
AVRT- Cancer Prevention Program
​
The COC Protocol - Adjunctive Therapy for Cancer Patients

Investor Presentation


Watch Torrey Hills Capital Presentation - January 2023

Annual General and Special Meeting
​Conference Call
 

Event Date: Wednesday June 7, 2023
Time: 2:00pm ET
Webcast Link: https://www.gowebcasting.com/12586 
Conference Call Numbers 
Canada/USA TF: 1-800-319-4610 

Toronto Toll: +1-416-915-3239 
International Toll: +1-604-638-5340 

StageZero Life Sciences Q3 2022 Earnings Call / Presentation
Access Presentation

In The News

StageZero Life Sciences was recently featured on BNN Bloomberg.

© 2021 [http://www.B-TV.com%3c/a]www.B-TV.com. All Rights Reserved.


Investor Relations Contacts
James R. Howard-Tripp 
Chairman and CEO
[email protected]

Rebecca Greco
Investor Relations

[email protected] 
​1-855-420-7140 ext 1838

Corporate Headquarters
​30-70 East Beaver Creek Road

Richmond Hill, ON L4B 3B2

[email protected]

Stay In Touch! Subscribe to Our Investor Updates

Picture
StageZero Life Sciences. Ltd.
​30-70 East Beaver Creek Road
Richmond Hill, Ontario L4B 3B2

StageZero Life Sciences, Inc.
​3705 Saunders Avenue
Richmond, VA 23227
​TEL: 855.420.7140 
Contact Information

Notice of Privacy Practices | Terms & Conditions | Privacy Statement & Policy | Licensing & Accreditation
  • About
    • Our Science
    • Publications
    • Board of Directors
    • Partners
    • Scientific Advisory Board
  • Cancer Testing
    • Aristotle-Test
    • AVRT Cancer Prevention
    • Employers
    • Firefighters
    • ColonSentry
  • Physicians
    • Establish an Account
    • Order Supplies
  • INVESTORS
    • Corporate Governance
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In the News
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment